International multi-center validation of an intermediate-risk subclassification of prostate cancer treated with radical treatment without hormone therapy

The NCCN guidelines recently endorsed a subclassification of intermediate-risk prostate cancer (IR-PCa) into favourable (FIR) and unfavourable (UIR) subgroups. However, this subclassification was developed in a treatment-heterogeneous cohort, hence the natural history of androgen deprivation treatment (ADT)-na ïve FIR- and UIR-PCa remains unknown.

Source: The Journal of Urology - August 25, 2018 Category: Urology & Nephrology Authors: A. Berlin, F.Y. Moraes, N. Sanmamed, R. Glicksman, A. Koven, O. Espin-Garcia, E.T.T. Leite, J.L.F. Silva, R. Gadia, M. Nesbitt, C.N. Catton, S. Kaffenberger, S.S. Salami, T.M. Morgan, J.W.D. Hearn, W.C. Jackson, R. Mehra, P. Chung, N.E. Fleshner, Z.S. Zum Source Type: research